The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
based on these pathways you know what is the marker we want to be looking at actually it's probably p-o-a surprisingly not a fatty acid but what this tells us is that when someone has consumed carbohydrates above their individual tolerance that poa level is going to be a great biomarker it's going to go up as again a protective mechanism in the liver
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
what is the marker we want to be looking at actually it's probably p-o-a surprisingly not a fatty acid but what this tells us is that when someone has consumed carbohydrates above their individual tolerance that poa level is going to be a great biomarker it's going to go up as again a protective mechanism in the liver